Renaissance Technologies LLC Raises Position in Addus HomeCare Corporation $ADUS

Renaissance Technologies LLC lifted its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 64.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 80,489 shares of the company’s stock after acquiring an additional 31,689 shares during the quarter. Renaissance Technologies LLC’s holdings in Addus HomeCare were worth $7,538,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Capital Research Global Investors lifted its position in Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after purchasing an additional 268,192 shares during the period. Vanguard Group Inc. increased its position in Addus HomeCare by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock worth $140,531,000 after purchasing an additional 10,501 shares during the period. Wasatch Advisors LP increased its position in Addus HomeCare by 0.8% during the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock worth $110,467,000 after purchasing an additional 7,089 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Addus HomeCare by 11.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after buying an additional 78,415 shares in the last quarter. Finally, State Street Corp raised its stake in shares of Addus HomeCare by 0.9% during the 4th quarter. State Street Corp now owns 702,229 shares of the company’s stock worth $75,412,000 after buying an additional 6,561 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 788 shares of company stock valued at $73,506. 4.10% of the stock is currently owned by corporate insiders.

Addus HomeCare Price Performance

ADUS stock opened at $116.79 on Tuesday. The firm has a 50 day moving average of $102.16 and a 200-day moving average of $101.45. The company has a market cap of $2.18 billion, a price-to-earnings ratio of 21.59, a PEG ratio of 1.58 and a beta of 0.87. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. The business had revenue of $377.41 million for the quarter, compared to analysts’ expectations of $376.24 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The company’s revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.49 EPS. As a group, equities analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ADUS. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Monday, May 18th. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Finally, Barclays boosted their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $131.50.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.